SSRP1 and cancer: This pathway could be an attractive target for cancer therapy as its modulation might restore normal histone H1 incorporation onto chromatin in SSRP1 overexpressing tumors and in cancer stem cells bearing reduced levels of histone H1 (refs. 16,17), thus limiting DNA replication and cell proliferation.